Brief: Made Scientific, Hemogenyx Partner to Advance Hg-Ct-1 CAR-T Therapy for AML
08/09/2025 14:12
Sept 8 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: MADE SCIENTIFIC AND HEMOGENYX PHARMACEUTICALS ANNOUNCE TECHNOLOGY TRANSFER AND MANUFACTURING PARTNERSHIP TO ADVANCE HG-CT-1, AN AUTOLOGOUS CAR-T CELL THERAPY FOR ACUTE MYELOID LEUKEMIA Source text: ID:nPnbpRS2ca Further company coverage: HEMO.L ((Reuters.Briefs@thomsonreuters.com;))